Nocturnal worsening of symptoms affects a large number of patients suf
fering from asthma. Recent studies show that airway inflammation under
lies nocturnal awakenings and increased airway hyperreactivity. These
studies, however, yield conflicting results concerning the pathogenesi
s of the disease, making it difficult to understand the mechanisms inv
olved in sustaining nocturnal asthma. This article reviews the princip
al pathogenetic mechanisms of nocturnal asthma, showing that worsening
of symptoms at night may be the result of a more severe disease as we
ll as of increased inflammation at night and higher susceptibility. We
also review the pharmacologic treatment of nocturnal asthma which is
mainly based on antiinflammatory treatment with inhaled or oral steroi
ds or combined therapies with theophylline and beta(2) agonists. The a
ctivity of antileukotrine compounds in asthma is also summarized.